Metropolitan Life Insurance CO Ampio Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.56 - $1.71 $18,182 - $55,521	-32,469 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$1.21 - $1.8 $39,287 - $58,444	32,469 New	32,469 $53,000
Q3 2021 Mar 30, 2023	SELL	$1.21 - $1.8 $34,131 - $50,774	-28,208 Reduced 46.49%	32,469 $53,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $34,131 - $50,774	-28,208 Reduced 46.49%	32,469 $54,000
Q2 2021 Jun 21, 2023	BUY	$1.56 - $1.98 $94,656 - $120,140	60,677 New	60,677 $101,000
Q2 2021 Mar 30, 2023	BUY	$1.56 - $1.98 $94,656 - $120,140	60,677 New	60,677 $101,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $94,656 - $120,140	60,677 New	60,677 $101,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.